Skip to content

Radiofrequence Microtenotomy for Treatment of Achilles Tendinose

Treatment of Achilles Tendinose

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03274557
Acronym
RFM
Enrollment
40
Registered
2017-09-07
Start date
2017-01-02
Completion date
2018-12-30
Last updated
2019-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Achilles Pain

Keywords

Achilles, tendinose, tendinopathy, pain

Brief summary

Prospective randomized controlled study using radio-frequency microtenotomy or physical therapy (eccentric training) for treatment of Achilles tendinose

Detailed description

Achilless tendinosis is a major clinical problem. There is a need for new studies to map the effectiveness of treatment. This study will compare treatment effectiveness between traditional physical therapy with surgical treatment using (RFM). The tendinosis grade will be evaluated using MRI and /or ultrasound before and after intervention. The outcome measurment include VAS and function using ( FAOS FOOT & ANKLE SURVEY) at 6,12 weeks and 6, 12 months after intervention.

Interventions

PROCEDURERFM

Sponsors

University Hospital of North Norway
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

To evaluate improvement of VAS and functionality before and after treatment of Achilles tendinosis using radiofrequency-plasma based microtenotomy in comparison to traditional physical therapy.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Patients with pain in Achilles tendon for at least 6 weeks. * MR / ultrasound confirms diagnosis tendinose. * Pain in sport and daily activities

Exclusion criteria

Other co-morbidity that constitutes contraindication for surgery, serious illness, bad compliance

Design outcomes

Primary

MeasureTime frameDescription
Pain reduction6.12 weeks and 6,12 monthsPain reduction. Change of pain from baseline measured with VAS

Secondary

MeasureTime frameDescription
Function6.12 weeks and 6,12 monthsChange from baseline in functionality measured by (FAOS) FOOT & ANKLE SURVEY

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026